Systematic review shows regional differences in HS comorbidity prevalence across North America, Europe, and Asia
Regional differences in health risks for hidradenitis suppurativa patients
This systematic review and meta-analysis examines the prevalence of hidradenitis suppurativa-associated comorbidities across North America, …
A meta-analysis reveals how hidradenitis suppurativa patients in North America, Europe, and the Middle East/Asia face different odds for dia…
Meta-analysis shows dietary nitrate supplementation lowers systolic blood pressure and cholesterol in adults with obesity
Beetroot and Greens May Lower Blood Pressure and Cholesterol
This systematic review and meta-analysis evaluated dietary nitrate supplementation in adults with obesity.
Eating more nitrate-rich vegetables like beets and spinach may lower blood pressure and cholesterol in people with obesity, even if the scal…
Narrative review examines multimorbidity impact on sepsis morbidity and mortality outcomes
Sepsis Risk Skyrockets When You Have Multiple Chronic Conditions
This narrative review synthesizes evidence regarding sepsis in patients with multimorbidity including type 2 diabetes and heart failure.
Common chronic diseases like diabetes and heart failure create hidden traps that make sepsis much harder to fight and treat.
Narrative review links ultra-processed food to obesity and multiple metabolic conditions
Is Ultra-Processed Food Driving Obesity And Infertility
This narrative review examines the association between ultra-processed food (UPF) consumption and adverse health outcomes.
Ultra-processed foods might hurt your health by causing weight gain or by acting directly on your body without weight gain at all.
Narrative review explores gut metabolites postbiotics obesity fatty liver and bone loss associations
Your Gut Microbes May Be Secretly Stealing Your Bone Strength
This narrative review examines the relationship between gut metabolites, postbiotics, and conditions including obesity, fatty liver, and bon…
A leaky gut can block calcium and vitamin D from reaching your bones, raising fracture risk.
Semaglutide high dose for weight reduction in people with Type 2 Diabetes
New drug helps obese diabetics lose weight and control sugar
This randomized controlled trial in 512 people with excess weight and Type 2 Diabetes compared high-dose semaglutide to placebo and lower do…
New research shows a specific injection helps people with obesity and diabetes lose weight and control their blood sugar levels better than …
Multicomponent lifestyle interventions impact dietary habits and sleep duration in college-attending young adults
Lifestyle changes help college students eat more fruits and vegetables
This secondary analysis of two multi-site randomized controlled trials evaluated multicomponent lifestyle interventions in college-attending…
New data shows that multi-part lifestyle programs can boost healthy eating and sleep duration for young adults in college.
Network Meta-Analysis Finds Tirzepatide and Semaglutide Most Effective for Weight Loss in Adults
New Weight Loss Drugs Protect Your Heart and Lower Death Risk
A systematic review and network meta-analysis of 63,909 adults found that all obesity medications produced greater weight loss than placebo.
New data from 66 trials shows top obesity drugs significantly reduce heart events and death while helping with liver and joint pain issues f…
Protocol for culturally adapted cardiovascular dance intervention in Mapuche women with obesity and cardiometabolic disorders
Study protocol for dance intervention in Indigenous Chilean community
This study protocol describes a randomized controlled trial involving 22 Mapuche women with overweight, obesity, or cardiometabolic disorder…
A new study protocol plans to test culturally adapted dance versus traditional exercise for health in an Indigenous Chilean community.
Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models
How Space Travel Is Unlocking New Ways to Fight Obesity and Diabetes
This narrative review synthesizes evidence from human studies, animal models, and in vitro experiments regarding microgravity and metabolic …
This research shows that the same health problems astronauts face in space are happening to people on Earth who sit too much, and it may lea…
MCH1 Receptor Antagonist RGH-706 Shows Weight Loss in Preclinical and Early Clinical Study
New Drug Targets Hunger Brain Signals to Help Shed Pounds
A preclinical and phase I/II study evaluated the MCH1 receptor antagonist RGH-706 for obesity and Prader-Willi Syndrome.
Scientists found a new medicine that may help people lose weight by turning off hunger signals.
GZR18 showed weight loss in Chinese adults with overweight or obesity in a phase 1b/2a trial
New Drug Cuts Weight by Nearly 20% in Just 35 Weeks
In this randomized, placebo-controlled phase 1b/2a trial, 60 Chinese adults with overweight or obesity received GZR18 or placebo.
This new treatment shows huge promise for helping people reach their weight goals without daily pills.